Pesquisas alternativas:
nor complex » norc complex (Expandir a Pesquisa), tor complex (Expandir a Pesquisa), cor complex (Expandir a Pesquisa)
meg newly » men newly (Expandir a Pesquisa), meet newly (Expandir a Pesquisa), may newly (Expandir a Pesquisa)
case new » cases new (Expandir a Pesquisa), cause new (Expandir a Pesquisa), caste new (Expandir a Pesquisa)
com meg » com meu (Expandir a Pesquisa), com mel (Expandir a Pesquisa), com mag (Expandir a Pesquisa)
3 neil3 » _ neil3 (Expandir a Pesquisa), 3 nfil3 (Expandir a Pesquisa)
amr now » apmr now (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
5 nor » _ nor (Expandir a Pesquisa), 5 non (Expandir a Pesquisa), 2 nor (Expandir a Pesquisa)
comoany » comoanti (Expandir a Pesquisa)
nor complex » norc complex (Expandir a Pesquisa), tor complex (Expandir a Pesquisa), cor complex (Expandir a Pesquisa)
meg newly » men newly (Expandir a Pesquisa), meet newly (Expandir a Pesquisa), may newly (Expandir a Pesquisa)
case new » cases new (Expandir a Pesquisa), cause new (Expandir a Pesquisa), caste new (Expandir a Pesquisa)
com meg » com meu (Expandir a Pesquisa), com mel (Expandir a Pesquisa), com mag (Expandir a Pesquisa)
3 neil3 » _ neil3 (Expandir a Pesquisa), 3 nfil3 (Expandir a Pesquisa)
amr now » apmr now (Expandir a Pesquisa)
l com » l como (Expandir a Pesquisa), e com (Expandir a Pesquisa), l con (Expandir a Pesquisa)
5 nor » _ nor (Expandir a Pesquisa), 5 non (Expandir a Pesquisa), 2 nor (Expandir a Pesquisa)
comoany » comoanti (Expandir a Pesquisa)
1
Assuntos:
“...Case Report...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Assuntos:
“...Case Report...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Assuntos:
“...Case Report...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Scheidt, Carl E, Baumann, Kathrin, Katzev, Michael, Reinhard, Matthias, Rauer, Sebastian, Wirsching, Michael, Joos, Andreas
Publicado em 2014
Assuntos:
“...Case Report...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Roux, Enora Le, Menesguen, Florence, Tejedor, Isabelle, Popelier, Marc, Halbron, Marine, Faucher, Pauline, Malivoir, Sabine, Polak, Michel, Poitou, Christine, Touraine, Philippe
Publicado no J Endocr Soc (2020)
“... follow-up. Results. Since 3 years, 500 patients benefited from the case management mainly...”Publicado no J Endocr Soc (2020)
Obter o texto integral
Obter o texto integral
Artigo
6
Por Allen, Pauline, Osipovič, Dorota, Shepherd, Elizabeth, Coleman, Anna, Perkins, Neil, Garnett, Emma, Williams, Lorraine
Publicado no BMJ Open (2017)
“... that cooperation was necessary. NHS England's policy document, The Five Year Forward View (‘5YFV’) of 2014 placed...”Publicado no BMJ Open (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Catarina Allegue, Mònica Coll, Jesus Mates, Oscar Campuzano, Anna Iglesias, Beatriz Sobrino, Maria Brion, Jorge Amigo, Angel Carracedo, Pedro Brugada, Josep Brugada, Ramon Brugada
Publicado em 2015-01-01
“... genetic variations in AKAP9 including a de novo genetic variation in 3 positive cases; 5 genetic...”Publicado em 2015-01-01
Obter o texto integral
Artigo
8
Por Allegue, Catarina, Coll, Mònica, Mates, Jesus, Campuzano, Oscar, Iglesias, Anna, Sobrino, Beatriz, Brion, Maria, Amigo, Jorge, Carracedo, Angel, Brugada, Pedro, Brugada, Josep, Brugada, Ramon
Publicado no PLoS One (2015)
“..., GPD1L, HCN4, JUP, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNQ1, NOS1AP, PKP2, RYR2, SCN1B, SCN3B...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Lu, Hsiao-Mei, Li, Shuwei, Black, Mary Helen, Lee, Shela, Hoiness, Robert, Wu, Sitao, Mu, Wenbo, Huether, Robert, Chen, Jefferey, Sridhar, Srijani, Tian, Yuan, McFarland, Rachel, Dolinsky, Jill, Tippin Davis, Brigette, Mexal, Sharon, Dunlop, Charles, Elliott, Aaron
Publicado no JAMA Oncol (2018)
“... cancer risk: ATM (odds ratio [OR], 2.97; 95% CI, 1.67-5.68), CHEK2 (OR, 2.19; 95% CI, 1.40-3.56), PALB2...”Publicado no JAMA Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Stanković Vlada
Publicado em 2006-01-01
“... to these works renders their sense clearer and their complex allusions more readily understood. This is a matter...”Publicado em 2006-01-01
Obter o texto integral
Artigo
11
Por Clément Boussardon, Marie-Laure Martin-Magniette, Marie-Laure Martin-Magniette, Marie-Laure Martin-Magniette, Béatrice Godin, Abdelilah Benamar, Benjamin Vittrant, Sylvie Citerne, Tristan Mary-Huard, Tristan Mary-Huard, David Macherel, Loïc Rajjou, Françoise Budar
Publicado em 2019-02-01
“... plants with natural and new genomic compositions. All three traits were modified by cytonuclear...”Publicado em 2019-02-01
Obter o texto integral
Artigo
12
Por Thomas Johnson
Publicado em 2018-04-01
“... synchronic slices of classificatory assemblages. Through seven in-depth case studies in three chronological...”Publicado em 2018-04-01
Obter o texto integral
Artigo
13
Por Frederika Welle Donker
Publicado em 2016-11-01
“... to improve existing applications and work processes rather than to create new products. The case study...”Publicado em 2016-11-01
Obter o texto integral
Artigo
14
Por Taft, Teresa, Weir, Charlene, Kramer, Heidi, Facelli, Julio
Publicado no J Clin Transl Sci (2018)
“... in case we need to notify them of. “this person’s possible having an adverse event. Look into it more.” (3...”Publicado no J Clin Transl Sci (2018)
Obter o texto integral
Obter o texto integral
Artigo
15
“... apresentar um referencial teórico sobre o desenvolvimento do IBI para riachos brasileiros, com base na...”
Obter o texto integral
Obter o texto integral
Online
16
Publicado no Cell Prolif
(2002)
“...) and SPF (r = 0.77). P53 immunoreactivity was present in 71.4% of the tumours, whereas 39.3% of cases were...”Obter o texto integral
Obter o texto integral
Artigo
17
Por Wondale, Biniam, Medhin, Girmay, Abebe, Gemeda, Tolosa, Samuel, Mohammed, Temesgen, Teklu, Takele, Pieper, Rembert, Ameni, Gobena
Publicado no Infect Drug Resist (2018)
“... MTBDRplus assay, two of the 153 isolates (1.3%) of the new cases were mono-resistant for rifampicin (RIF...”Publicado no Infect Drug Resist (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Wondale B, Medhin G, Abebe G, Tolosa S, Mohammed T, Teklu T, Pieper R, Ameni G
Publicado em 2018-09-01
“... of mono-resistance was 9.2% (11/119) in the new cases, although neither poly-resistance nor multidrug...”Publicado em 2018-09-01
Obter o texto integral
Artigo
19
Por Norliza Muhamad Yusof, Muhamad Luqman Sapini, Lidiya Irdeena Az’hari, Nor Akma Hanis Roslee, Siti Noor Afiqah Rahmat, Siti Hidayah Muhad Salleh
Publicado em 2022-04-01
“...This study aims to forecast the new number of positive cases of COVID-19 using the logistic map...”Publicado em 2022-04-01
Obter o texto integral
Artigo
20
Por Bayliss, Elizabeth, Bronsert, Michael, Reifler, Liza, Ellis, Jennifer, McQuillan, Deanna, Steiner, John, Fairclough, Diane
Publicado em 2012
“... following a new diagnosis of cancer. Such decisions must take into account cancer prognosis, cardiovascular...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Artigo